The IPO Buzz: Gemini (GEMI) Trims IPO & Prices it at $28 – $2 Above Range
Gemini Space Station (GEMI), a cryptocurrency exchange founded by the Winklevoss twins, priced its IPO at $28.00 – $2.00 above the top of its recently increased price range – and trimmed the deal’s size at pricing to 15.2 million shares – down from 16.7 million shares in the prospectus – to raise $425.6 million on Thursday night, Sept. 11, 2025. At pricing, Gemini had a market cap of about $3.3 billion. Gemini’s stock is expected to start trading today – Friday, Sept. 12, 2025 – on the NASDAQ. The terms in the prospectus had called for a price range of $24.00 to $26.00 – raised from the original price range of $17.00 to $19.00.
Goldman Sachs, Citigroup, Morgan Stanley and Cantor led the joint book-running team.
Evercore ISI, Mizuho, Truist Securities, Cohen & Company Capital Markets, Keefe, Bruyette & Woods (A Stifel Company), Needham & Co. and Rosenblatt were also joint book-runners, according to the S-1/A filing.
About 30 percent of the IPO was earmarked for retail – to Robinhood and other brokers, according to an S-1/A filing on Tuesday, Sept. 9, 2025:
“We currently anticipate that up to 30% (30 percent) of the shares of Class A common stock offered hereby will, at our request, be offered to retail investors through Robinhood Financial, LLC, SoFi Securities LLC, Futu Securities International (Hong Kong) Limited, Moomoo Financial Singapore Pte. Ltd, Moomoo Financial Inc., Webull Financial LLC and/or other platforms, as selling group members, via their online brokerage platforms. These platforms are not affiliated with us.”
Gemini disclosed on Tuesday that NASDAQ would become a strategic investor in the company by buying $50 million of stock in a private placement concurrent with the IPO. Reuters reported on the agreement – citing people familiar with the situation – in a story early today before the federal filing was available.
Gemini Space Station was founded in 2014 by Cameron and Tyler Winklevoss, also known as the Winklevoss twins.
In the prospectus, Gemini said that it caters to individual retail users of crypto as well as to institutional investors, including asset managers, hedge funds, proprietary trading firms and corporations.
“As of June 30, 2025, we serve approximately 523,000 MTUs (monthly transacting users) and approximately 10,000 institutions in over 60 countries, with over $18 billion of assets on our platform, over $285 billion in lifetime trading volume, and over $800 billion in transfers processed on our platform. Since our founding, we have watched the overall crypto market capitalization expand from under $10 billion to over $3 trillion as users discover the onchain world.”
Gemini is not profitable, according to the prospectus: Net loss of $399.65 million on revenue of $137.25 million for the 12 months that ended June 30, 2025.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.
Source: https://www.iposcoop.com/the-ipo-buzz-gemini-gemi-trims-ipo-prices-it-at-28-2-above-range/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
